Management of hormone-secreting pituitary microadenomas.
Experience with 22 patients with pituitary microadenoma is discussed. The diagnosis was based on examination of the contour of the normally sized sella turcica by multidirectional thin-layer tomography, and measurement of the pituitary hormone reserve capacity. Of the patients 13 had a microprolactinoma and 9 a microsomatotropinoma; 13 were subjected to trans-sphenoidal microadenomectomy and 14 received drug treatment. The problems of diagnostics and the choice of therapy are discussed.
D000236:Adenoma / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007016:Hypophysectomy / Q000379:methods; D008297:Male; D008875:Middle Aged; D010908:Pituitary Hormones, Anterior / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D011388:Prolactin / Q000378:metabolism
D010908:Pituitary Hormones, Anterior; D001971:Bromocriptine; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone